UCB stock costs EUR 204.90, 29.2 percent below its 52-week high

Published on 10/08/2026 at 15:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

On October 8, 2026, UCB stock stands at EUR 204.90 after EUR 203.55, plus 0.7 percent. Market value is EUR 39.1 billion and P/E is 17.8.

Schwarzweiß-Reportagefoto einer Wissenschaftlerin bei der Untersuchung einer Petrischale im Labor — UCB S.A. (BE0003739530) dokumentarisch: authentische Schwarzweiß-Reportage einer Wissenschaftlerin bei sorgfältiger Laboranalyse mit Petrischale, Illustration mit AI erstellt.

UCB stock (ISIN BE0003739530) was trading at EUR 204.90 at Lang & Schwarz on October 8, 2026 at 3:37 p.m. CEST, plus 0.66 percent versus the prior close of EUR 203.55. The price was 29.22 percent below its 52-week high of EUR 289.50.

Intraday quote stays near EUR 205

The Lang & Schwarz bid was EUR 204.80 and the ask was EUR 205.00 at the same timestamp. The intraday quote therefore sat within a EUR 0.20 bid-ask spread, while the reference price remained above the EUR 198.75 52-week low.

Range leaves a wide valuation gap

UCB's EUR 204.90 quote was 29.22 percent below the EUR 289.50 52-week high and 3.10 percent above the EUR 198.75 low, using the finance quote dated October 8, 2026. The current position places the stock much closer to its annual low than its annual high.

UCB had a market capitalization of EUR 39.1 billion and a P/E ratio of 17.77 on October 8, 2026. The finance quote also showed average daily volume of 232,286 shares against 52,014 shares traded at the recorded timestamp.

Comparison with peers

As of October 8, 2026:
UCB: plus 0.74 percent, P/E 17.77, market capitalization EUR 39.1 billion
AbbVie: minus 0.40 percent, P/E 75.91, market capitalization USD 477.5 billion
Galderma Group: unchanged, P/E 47.79, market capitalization CHF 37.9 billion

Target and next reporting date

According to Markets Insider on October 2, 2026, Barclays maintained a Hold rating on UCB with a EUR 260.00 price target. The target lies 26.89 percent above the Lang & Schwarz price of EUR 204.90.

GuruFocus lists February 26, 2027 as UCB's next earnings date. The calendar entry gives investors a dated reference for the next scheduled reporting point.

UCB stock remains below its high

UCB stock was trading at EUR 204.90 at Lang & Schwarz on October 8, 2026 at 3:37 p.m. CEST, plus 0.66 percent versus the Lang & Schwarz prior close of EUR 203.55. The further course of trading is shown by the continuously updated real-time quote of UCB stock.